HITS-Bio is the first tool to bioprint directly on a wound.

Three-dimensional (3D) printing isn’t just a way to produce material products quickly. It also offers researchers a way to develop replicas of human tissue that could be used to improve human health, such as building organs for transplantation, studying disease progression and screening new drugs. While researchers have made progress over the years, the field has been hampered by limited existing technologies unable to print tissues with high cell density at scale.

A team of researchers from Penn State have developed a novel bioprinting technique that uses spheroids, which are clusters of cells, to create complex tissue. This new technique improves the precision and scalability of tissue fabrication, producing tissue 10-times faster than existing methods. It further opens the door to developing functional tissues and organs and progress in the field of regenerative medicine, the researchers said.

They published their findings in Nature Communications.

Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink, recently featured in Advanced Healthcare Materials, introduces a way to precisely guide the growth and organization of tiny blood vessels within 3D-bioprinted tissues. The tiny blood vessels mimic the intricate networks found in the human body.

3D-printed organs have the potential to revolutionize medicine by providing solutions for organ failure, and tissue damage and developing new therapies. But a major challenge is ensuring these printed tissues receive enough nutrients and oxygen, which is critical for their survival and function. Without blood vessels, these tissues can’t efficiently obtain nutrients or remove waste, limiting their effectiveness. Therefore, the ability to 3D-bioprint blood vessels is a crucial advancement.

Tissue engineers could already position blood vessels during the bioprinting process, but these vessels often remodel unpredictably when cultured in the lab or implanted in the body, reducing the effectiveness of the engineered tissue. The programmable bioink developed by the University of Twente team addresses this issue by providing dynamic control over vessel growth and remodeling over time. This opens new possibilities for creating engineered tissues with long-term functionality and adaptability.

Biomedical engineers from the University of Melbourne have invented a 3D printing system, or bioprinter, capable of fabricating structures that closely mimic the diverse tissues in the human body, from soft brain tissue to harder materials like cartilage and bone.

This cutting-edge technology offers cancer researchers an advanced tool for replicating specific organs and tissues, significantly improving the potential to predict and develop new pharmaceutical therapies. This would pave the way for more advanced and ethical drug discovery by reducing the need for animal testing.

Head of the Collins BioMicrosystems Laboratory at the University of Melbourne, Associate Professor David Collins said: In addition to drastically improving print speed, our approach enables a degree of cell positioning within printed tissues. Incorrect cell positioning is a big reason most 3D bioprinters fail to produce structures that accurately represent human tissue.

This development comes from…

Researchers have designed a high-speed 3D bioprinter to accurately print human tissues.

Interestingly, this advanced bioprinter is capable of fabricating a diverse array of tissues, including both soft brain tissue and harder materials such as cartilage and bone.

This development comes from biomedical engineers from the University of Melbourne.

A way to re grow new parts, perfect DNA match, eventually? Will take Agi / ASI to realize full potential, we ll see.

For this, the researchers have created a compact bioprinter to develop biological tissues with microfilament structures. He is now working to bring this technology to market.

“Our aim is to create human tissue models for high-throughput drug screening and other applications,” Liu said.

The human body is composed of various tissues, each with specific structures and functions. These tissues, like muscles, tendons, connective tissue, and nervous tissue, exhibit organized cellular arrangements. This organization is crucial for their proper functioning.

A research team at the University of Virginia School of Engineering and Applied Science has developed what it believes could be the template for the first building blocks for human-compatible organs printed on demand.

Liheng Cai, an assistant professor of materials science and engineering and chemical engineering, and his Ph.D. student, Jinchang Zhu, have made biomaterials with controlled mechanical properties matching those of various human tissues.

“That’s a big leap compared to existing bioprinting technologies,” Zhu said.

Year 2023 face_with_colon_three

Scientists at Stanford University have developed a method for 3D-printing human heart tissue that could eventually be implanted into patients.

0:00 Intro.
0:45 How scientists are 3D Printing heart parts.
1:25 Bioprinting process.
2:45 Bio-printed heart valve.
3:44 Outro.

Read the CNET article.
Stanford Scientists Use Stem Cells to 3D-Print Heart Tissue.
https://www.cnet.com/science/stanford…

Never miss a deal again! See CNET’s browser extension https://bit.ly/3lO7sOU
Follow us on TikTok: / cnetdotcom.
Follow us on Instagram: / cnet.
Follow us on Twitter: / cnet.
Like us on Facebook: / cnet.

#science #sciencenews #wtf

Year 2018 face_with_colon_three

Pediatric Research volume 83, pages 223–231 (2018) Cite this article.

I have a new essay out via the wonderful site Merion West. The article is based on some of my experimental writings at Oxford. I hope you’ll read and consider it. I’m highly worried life extension science isn’t moving forward fast enough!

“Sadly, biological humans are likely to be mortal for centuries more, unless a dramatic increase of both resources and life extension scientists are marshaled.”

Certain well-known gerontologists and longevity experts around the world believe that sometime in this century—probably in the next 15–50 years—medicine will likely overcome and cure most forms of disease, and even death itself. Billionaires such as Meta’s Mark Zuckerberg, Amazon’s Jeff Bezos, Alphabet’s Larry Page, and Oracle’s Larry Ellison have jumped on board, pledging billions of dollars to “conquering all disease by this century” and mortality altogether.

These business titans hope age reversal techniques via genetic editing therapies, stem cell rejuvenation, 3D bioprinting of organs, and the widespread creation of synthetic organs like artificial hearts could keep people indefinitely young and healthy. If biological human death from disease and aging are overcome, then only catastrophic accidental death—such as an airplane crash or incineration—can kill people. (Accidental death in this vein accounts for about seven percent of all deaths in the United States.)

Transhumanists believe that the human being is like a machine—an entity that can be fixed and made to overcome nearly all biological death. The question is how fast can this be done? If the human being is indeed a machine-like entity as nearly all credible scientists propose, then the answer almost certainly rests not in the limits of biology but, rather, in the amount of work and resources put into the life extension field.